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TORC1 and TORC2 work together to regulate 
ribosomal protein S6 phosphorylation in 
Saccharomyces cerevisiae 
ABSTRACT Nutrient-sensitive phosphorylation of the S6 protein of the 40S subunit of the 
eukaryote ribosome is highly conserved. However, despite four decades of research, the 
functional consequences of this modification remain unknown. Revisiting this enigma in Sac-
charomyces cerevisiae, we found that the regulation of Rps6 phosphorylation on Ser-232 and 
Ser-233 is mediated by both TOR complex 1 (TORC1) and TORC2. TORC1 regulates phos-
phorylation of both sites via the poorly characterized AGC-family kinase Ypk3 and the PP1 
phosphatase Glc7, whereas TORC2 regulates phosphorylation of only the N-terminal phos-
phosite via Ypk1. Cells expressing a nonphosphorylatable variant of Rps6 display a reduced 
growth rate and a 40S biogenesis defect, but these phenotypes are not observed in cells in 
which Rps6 kinase activity is compromised. Furthermore, using polysome profiling and ribo-
some profiling, we failed to uncover a role of Rps6 phosphorylation in either global transla-
tion or translation of individual mRNAs. Taking the results together, this work depicts the 
signaling cascades orchestrating Rps6 phosphorylation in budding yeast, challenges the no-
tion that Rps6 phosphorylation plays a role in translation, and demonstrates that observa-
tions made with Rps6 knock-ins must be interpreted cautiously.
INTRODUCTION
The target of rapamycin (TOR) signaling network plays an important 
role in the adaptation of cells to their changing environment by link-
ing extracellular and cell-intrinsic cues to the major cellular pro-
cesses that regulate growth. For example, TOR controls cell growth 
by regulating gene transcription, translation, ribosome biogenesis, 
autophagy, lipid synthesis, and actin polarization (Loewith and Hall, 
2011). In yeast, there are two TOR genes, TOR1 and TOR2, whereas 
in higher eukaryotes there is only one. TOR kinases are found in two 
functionally and structurally distinct multiprotein complexes named 
TOR complex 1 (TORC1) and TOR complex 2 (TORC2). Rapamycin, 
an antifungal and immunosuppressant macrolide, inhibits TORC1 
but not TORC2. When applied in low millimolar concentrations, caf-
feine also specifically inhibits TORC1 (Kuranda et al., 2006; Reinke 
et al., 2006; Wanke et al., 2008; Loewith and Hall, 2011). Pharmaco-
logical inhibition of TORC2 in yeast was achieved only recently with 
the characterization of an imidazoquinoline called NVP-BHS345 
(BHS), an ATP-competitive inhibitor of TOR that inhibits both com-
plexes (Shimada et al., 2013; Rispal et al., 2015).
In yeast, as well as in higher eukaryotes, arguably the best-char-
acterized substrates of TOR are members of the AGC family of 
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lation via Glc7/Shp1. Cells expressing nonphosphorylatable vari-
ants of Rps6 presented phenotypes associated with 40S ribosome 
biogenesis defects, but these phenotypes were not recapitulated 
under conditions in which wild-type (wt) Rps6 protein is hypophos-
phorylated. Cells expressing nonphosphorylatable variants of Rps6 
were partially resistant to the loss of Glc7 activity, suggesting that 
Rps6 hyperphosphorylation is toxic. Curiously, ribosome-footprint-
ing analyses revealed that neither Rps6 phosphorylation nor Ypk1–3 
activities are overtly involved in the regulation of gene expression at 
the level of transcription or translation and thus challenge the pres-
ent models on the function of Rps6 phosphorylation derived from 
studies in higher eukaryotes.
RESULTS
Rps6 is differentially phosphorylated on Ser-232 and 
Ser-233 in a TORC1- and TORC2-dependent manner
Rps6 is encoded by two paralogues, RPS6A and RPS6B, in S. cere-
visiae, which encode for identical proteins, Rps6A and Rps6B. Both 
proteins are phosphorylated on Ser-232 and -233, and knock-ins 
targeting these phosphorylation sites were made in both RPS6A 
and RPS6B genes.
To functionally characterize Rps6 phosphorylation, we initially 
generated antisera that recognize Rps6 proteins regardless of their 
phosphorylation status (Figure 1A). We also screened a number of 
commercially available antisera and found one (which we refer to as 
Rps6-PP) that cross-reacts with Rps6 when doubly phosphorylated 
on Ser-232 and -233 (Figure 1A). Immunoreactivity with this antise-
rum is lost if either or both of these serines are replaced with an ala-
nine (Rps6AA, Rps6SA, or Rps6AS; Figure 1A). We additionally investi-
gated immunoreactivity of Rps6 variants with antiserum recognizing 
phospho-RXXS*/T* motifs. Rps6SS and Rps6SA but not the Rps6AS 
variant are recognized by this antiserum (Figure 1A). This result im-
plies that either the antiserum cannot recognize Rps6 phosphory-
lated on Ser-233 alone or that Ser-233 can only be phosphorylated 
after prior Ser-232 phosphorylation. We believe that the first hy-
pothesis is correct, as we observe a slower SDS–PAGE migration of 
the Rps6AS variant compared with the Rps6AA variant (Supplemental 
Figure S1, B and C).
Using these antisera, we examined how Rps6 phosphorylation 
responds to TORC1 and TORC2 inhibition. Inhibition of TORC1 
with either rapamycin (Figure 1B) or caffeine (Supplemental Figure 
S1D) triggered rapid dephosphorylation of Ser-233 but not Ser-232. 
In contrast, inhibition of both TORC1 and TORC2 with BHS trig-
gered rapid dephosphorylation of both serines (Figure 1C). TORC1 
(Urban et al., 2007) and TORC2 (Y. Bouza, M. Piccolis, and R. Loe-
with, unpublished data) are sensitive to carbon quality, and consis-
tent with the BHS result, downshift in carbon quality also triggered 
rapid dephosphorylation of both serines (Figure 1D). Nitrogen de-
pletion also triggered dephosphorylation of both serines, with 
slower but otherwise parallel kinetics (Supplemental Figure S1E). 
Collectively these observations suggested that TORC1 regulates 
phosphorylation of Ser-233, whereas TORC1 and/or TORC2 regu-
late phosphorylation of Ser-232.
To distinguish between the two possibilities, we constructed a 
strain in which TORC2 activity could be inhibited upon addition of 
the plant hormone auxin, which triggered proteolysis of the essen-
tial TORC2 subunit Avo1 fused to an auxin-activated degron 
(Nishimura et al., 2009; Supplemental Figure S1F). Before this ex-
periment, we first confirmed that TORC1 and TORC2 activities in 
wild-type cells were not affected by auxin treatment per se (Supple-
mental Figure S1G). Subsequently, we found that inhibition of 
TORC2 resulted in Ser-232 dephosphorylation only when TORC1 
kinases. These include S6 kinases (S6Ks) and Sch9, which are phos-
phorylated by mammalian TORC1 (mTORC1) and yeast TORC1, 
respectively; and Akt/protein kinase B and Sgk1, and Ypk1 and 
Ypk2, which are phosphorylated by mTORC2 and TORC2, respec-
tively (Pearce et al., 2010; Loewith and Hall, 2011). Phosphorylation 
of AGC kinases by TOR complexes occurs in distinct, carboxyl-ter-
minal sequences known as the turn motif and hydrophobic motif 
and increases their activity (Pearce et al., 2010).
Ribosomal protein S6 (Rps6) was one of the first ribosomal pro-
teins found to undergo phosphorylation (Kabat, 1970; Gressner and 
Wool, 1974). Rps6 phosphorylation is conserved from yeast to mam-
malian cells. In higher eukaryotes, there are five phosphorylation 
sites on its carboxyl terminus, whereas only two of these sites (Ser-
232 and Ser-233), corresponding to Ser-235 and Ser-236 in higher 
eukaryotes, are conserved in yeast (Supplemental Figure S1A). Rps6 
phosphorylation is sensitive to nutrients, hormones, growth factors, 
and a variety of stress conditions (Meyuhas, 2008). In higher eukary-
otes, S6 kinases 1 and 2 (S6K1 and S6K2) are the major kinases 
phosphorylating Rps6 on several sites (S235/S236/S240/S244) in 
response to mTORC1 activity (Pende et al., 2004). Rps6 is addition-
ally phosphorylated by RSKs (90-kDa ribosomal protein S6 kinases) 
on S235/S236 downstream of mitogen-activated protein kinase sig-
naling (Roux et al., 2007). Members of casein kinase I kinase family 
were found to phosphorylate Rps6 on Ser-247 in response to mito-
genic stimuli (Hutchinson et al., 2011). Intriguingly, both TORC1 and 
TORC2 regulate Rps6 phosphorylation in fission yeast, via Psk1 and 
Gad8, respectively (Du et al., 2012; Nakashima et al., 2012). Rps6 
dephosphorylation is less well studied but, at least in mammals, ap-
pears to require the type 1 protein phosphatase (PP1) (Belandia 
et al., 1994; Hutchinson et al., 2011).
The major regulators of Rps6 phosphorylation in budding yeast 
remain unknown. Considering its role in translation and its ability to 
phosphorylate Rps6 in vitro, Sch9 was proposed to be the functional 
orthologue of S6 kinase in higher eukaryotes (Urban et al., 2007). 
However, phylogenetic analyses of the TOR signaling network has 
suggested that Ypk3, rather than Sch9, is more likely to be the S6 
kinase orthologue in S. cerevisiae (van Dam et al., 2011). Consis-
tently, YPK3 is orthologous to Schizosaccharomyces pombe PSK1. 
In addition, a recent study proposed that Ypk3 activity, but not Sch9 
activity, is required for Rps6 phosphorylation in vivo in budding 
yeast (Gonzalez et al., 2015).
Despite years of research, the physiological role of Rps6 phos-
phorylation remains mysterious. Knock-in mice expressing only the 
alanine-substituted nonphosphorylatable version of Rps6 exhibited 
severe phenotypes, including a reduced size, glucose intolerance, 
and muscle weakness (Ruvinsky et al., 2005). Studies in yeast, how-
ever, suggested that Rps6 phosphorylation had no observable ef-
fect on the growth of cells under different conditions (Kruse et al., 
1985; Johnson and Warner, 1987). Rps6 phosphorylation was once 
believed to specifically couple mTORC1 signals to the translation of 
so-called 5′-TOP mRNAs (Fumagalli, 2000), which predominantly 
encode proteins required for protein synthesis (Levy et al., 1991; 
Iadevaia et al., 2008). However, another mTORC1 effector, 4E-BP1, 
is now believed to serve in this capacity (Hsieh et al., 2012; Thoreen 
et al., 2012). More recently, Rps6 phosphorylation has again been 
linked to the translation machinery via regulation of the transcription 
of genes encoding ribosome biogenesis factors (Chauvin et al., 
2014).
Here we revisited Rps6 phosphorylation in the model eukaryote 
S. cerevisiae. We found that Rps6 phosphorylation is differentially 
regulated downstream of TORC1 via Ypk3 and TORC2 via Ypk1 and 
Ypk2. TORC1 additionally appears to regulate Rps6 dephosphory-
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was additionally inhibited (Figure 1E). Thus we conclude that 
TORC1 signals promote phosphorylation of both Ser-232 and Ser-
233, whereas TORC2 signals promote phosphorylation of Ser-232 
(Figure 4D).
TORC1 regulates Rps6 phosphorylation on Ser-233 via Ypk3
We screened a panel of kinase deletion mutants (Bodenmiller et al., 
2010) to identify the TORC1-effector kinase that phosphorylates 
Rps6. This screen demonstrated that Rps6 is hypophosphorylated 
on Ser-233 in ypk3Δ cells (Figure 2A and Supplemental Figure S2A). 
Using an analogue-sensitive, Ypk3-expressing strain, we also found 
that Ypk3 activity is required for phosphorylation of Rps6 on Ser-233 
upon glucose repletion (Figure 2B). In contrast, inhibition of ana-
logue-sensitive protein kinase A (tpk1as tpk2as tpk3as cells) did not 
trigger dephosphorylation of Rps6 (Supplemental Figure S2B), ar-
guing against a role for this related AGC-family kinase in Rps6 
phosphorylation.
Because Ypk3 is an AGC-family kinase, we predicted that it 
could be a direct substrate of TORC1. Consistent with this hypoth-
esis, we found that Ypk3 is hypophosphorylated upon TORC1 inhi-
bition with rapamycin (Figure 2C), carbon downshift (Supplemental 
Figure S2C), or nitrogen starvation (Supplemental Figure S2D) and 
that Ypk3 coprecipitates TORC1 in a rapamycin-sensitive manner 
(Figure 2D). Ypk3 phosphorylation was not obviously affected upon 
TORC2 inhibition (Supplemental Figure S2E) but was decreased 
upon direct inhibition of analogue-sensitive Ypk3 with 1NM-PP1 
(Figure 2B), suggesting that it autophosphorylates, which was con-
firmed by in vitro kinase assays (Figure 2E). Addition of TORC1 in 
the absence but not the presence of wortmannin further increased 
Ypk3 phosphorylation in vitro. Together, these observations strongly 
suggest that Ypk3 is a direct target of TORC1.
TOR targets a highly conserved hydrophobic motif at the C-ter-
minal end of AGC kinases. Based on the homology among Ypk1, 
Ypk2, and Ypk3, we predicted Ser-513 to be the residue phosphory-
lated within the hydrophobic motif of Ypk3 (Supplemental Figure 
S2F). Conversion of Ser-513 to Ala altered the SDS–PAGE mobility 
of Ypk3 but did not affect its catalytic activity (Supplemental Figure 
S2G). Substitution of this residue with glutamic acid and aspartic 
acid did not suppress the rapamycin-induced hypophosphorylation 
of Rps6 (unpublished data), suggesting that either these substitu-
tions do not adequately mimic phospho–Ser-513 or that TORC1 
regulates Ypk3 and/or Rps6 phosphorylation through additional 
mechanisms. To map other rapamycin-sensitive phosphorylation 
sites on Ypk3, we decided to immunoprecipitate Flag-tagged Ypk3 
from untreated and rapamycin-treated cells and analyze the phos-
phorylation patterns by mass spectrometry. This analysis revealed 
three rapamycin-sensitive sites in the N-terminus (S86, S92, S94) 
and three in the C-terminus of the protein (S505, S517, S519; Sup-
plemental Figure S2F). Alanine substitution of the N-terminal resi-
dues S86, S92, and S94 did not visibly alter the SDS–PAGE migra-
tion pattern or the activity of Ypk3 (Supplemental Figure S2G), and 
thus we decided to focus on the C-terminal phosphorylation sites. 
Intriguingly, alanine substitution of S505, S517, and S519 residues in 
combination with that of S513 (Ypk34A) greatly diminished the phos-
phorylation level of Rps6 nearly to the level observed in ypk3 cells 
(Supplemental Figure S2H). We substituted these four serines with 
aspartic acid to see whether the phosphomimetic Ypk3 could sup-
press Rps6 dephosphorylation induced by rapamycin. However, this 
was not the case (Supplemental Figure S2H), leading us to believe 
that Ypk3 is not the only factor through which TORC1 regulates 
Rps6 phosphorylation (see Discussion).
FIGURE 1: Rps6 phosphorylation is differentially regulated on 
Ser-232 and -233. (A) Western blot of denaturing total protein 
extracts prepared from yeast cells with the indicated genetic 
modifications. Membranes were probed with the following 
antibodies: rabbit anti–phospho-S6 ribosomal protein (S235/S236; 
Rps6-PP) or rabbit anti–phospho-Akt substrate (RXXS*/T*), 
together with guinea pig anti-Rps6. Binding of phosphospecific 
antibodies was revealed with IRDye 680CW–conjugated anti-
rabbit immunoglobulin G (IgG; red signal). Binding of anti-Rps6 
antibody was revealed with IRDye 800CW–conjugated anti-guinea 
pig IgG (green signal). (B, C) Exponentially growing wild-type cells 
were treated with 200 nM rapamycin or 100 μM BHS. After 
treatment, the cells were collected at the indicated time points. 
and protein extracts were processed as described. (D) Rps6 
phosphorylation status over time after a shift from glucose-
containing medium (SDGlc) to galactose-containing medium 
(SDGal). Glucose was added 60 min after the carbon downshift, 
and Rps6 rephosphorylation was followed over the subsequent 
20 min. (E) Rps6 phosphorylation status over time after TORC2 
inhibition (in cells expressing an Avo1-AID fusion protein treated 
with 100 μM indole-3-acetic acid [IAA]) and/or TORC1 inhibition 
with rapamycin. Sch9 and Ypk1 phosphorylations were additionally 
assessed as readouts of TORC1 and TORC2 activities, 
respectively.
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TOR complexes 1 and 2 regulate Rps6 phosphorylation 
on Ser-232 via Ypk1/2/3
Unlike Ser-233, we could still detect phosphorylation of Ser-232 in 
the absence of YPK3 (Figure 3A). Ypk1 and Ypk2 are bona fide sub-
strates of TORC2 (Kamada et al., 2005; Niles et al., 2012) and are 
also closely related to Ypk3, suggesting that all three kinases could 
redundantly mediate Rps6 phosphorylation on Ser-232. Loss of 
Ypk1 and/or Ypk2 function did not affect the phosphorylation levels 
of Rps6 (Figure 3A and Supplemental Figure S3A). However, inhibi-
tion of Ypk1 and Ypk2 in combination with rapamycin treatment 
FIGURE 2: TORC1 regulates Rps6 phosphorylation on Ser-233 via 
Ypk3. (A) Rps6 phosphorylation on Ser-233 is impaired in cells lacking 
Ypk3 activity. Rps6 phosphorylation in ypk3 cells expressing an empty 
vector (–), YPK3-FLAG (WT), or kinase-dead ypk3-FLAG (kd) was 
assessed by Western blot. Hog1 protein levels were assessed as a 
loading control. (B) A ypk3as strain was grown in SD medium with 2% 
glucose, filtered, and resuspended in SD with 2% galactose. After 1 h 
of incubation at 30°C, the culture was split into two: one 
supplemented with 2% glucose and DMSO, and the other with 2% 
glucose and 500 nM 1NM-PP1 to inhibit Ypk3as activity. Rps6 
phosphorylation status and Ypk3-FLAG and Hog1 protein levels were 
assessed at various time points before, during, and after carbon 
downshift as indicated. (C) The migration pattern of Ypk3-FLAG 
collected from exponentially growing cells expressing before and 
after treatment with 200 nM rapamycin was assessed by Western 
FIGURE 3: TOR complexes 1 and 2 regulate Rps6 phosphorylation on 
Ser-232 via Ypk1–3. (A) Individual deletion of neither YPK1 nor YPK2 
altered Rps6 phosphorylation. (B) Inhibition of Ypk1as with 1NM-PP1 in 
ypk2Δ ypk3Δ and ypk3Δ backgrounds triggered loss of Ser-232 
phosphorylation. (C) Inhibition of Ypk1as and Ypk3as with 1NM-PP1 
prevented Rps6 rephosphorylation upon glucose refeeding. (D) Ypk3 
phosphorylates Rps6 in vitro. Rps6 in yeast ribosomes was 
phosphorylated by wild-type Ypk3-FLAG purified from exponentially 
growing cells. Rapamycin treatment before purification reduced 
Ypk3-FLAG activity. Kinase-dead (kd) or nonphosphorylatable Ypk3 
variant (4A) also failed to phosphorylate Rps6 in vitro.
blot. (D) Ypk3-TAP interacts with Tor1. Protein extracts were prepared 
from vehicle- or rapamycin-treated (30 min) cells expressing or not 
Ypk3-TAP and/or HA3-Tor1. Ypk3 was immunoprecipitated using IgG 
Dynabeads, and associated proteins were detected by Western blot. 
(E) TORC1 phosphorylates Ypk3 in vitro. GST-Ypk3as purified from 
yeast was used as a substrate for TORC1 purified from yeast by 
immunoprecipitating Tco89-TAP. The combination of wortmannin 
(which inhibits TORC1) and 1NMPP1 (which inhibits GST-Ypk3as) was 
used to show the specificity of the kinase reaction.
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hands, expression of the RPS6AA alleles resulted in an almost 30% 
decrease in the proliferation rate (Figure 5A and Supplemental 
Figure S5A). The RPS6AA cells also had lower protein content than 
the wild-type cells as assessed by fluorescein isothiocyanate (FITC) 
staining and fluorescence-activated cell sorting (FACS) analysis 
(Figure 5B and Supplemental Figure S5B).
To explore the effect of Rps6 phosphorylation on global transla-
tion, we monitored the abundance of free 40S and 60S subunits, 
80S monosomes, and actively translating ribosomes (polysomes) in 
induced hypophosphorylation of Ser-232 (Supplemental Figure 
S3B). Next we combined the deletion of YPK3 with the deletion of 
YPK2 and an analogue-sensitive allele of YPK1. In the absence of 
the activities of all three kinases, both Ser-232 and Ser-233 were 
hypophosphorylated (Figure 3B). Rephosphorylation of Rps6 on 
both Ser-232 and Ser-233 upon refeeding of glucose also appeared 
to require the activity of all three Ypk kinases (Figure 3C), although 
we note that the contribution of Ypk2 to Rps6 phosphorylation ap-
pears to be minimal.
Wild-type Ypk3 but not inactive variants phosphorylated Rps6 
in vitro, strongly suggesting that Rps6 is a direct target of Ypk3 
(Figure 3D). Purified ribosomes were used as the source of Rps6 in 
this assay, as recombinant Rps6 was extremely unstable in our 
hands. Curiously, we failed to observe phosphorylation of Rps6 by 
Ypk1 in a similar assay (Supplemental Figure S3C). This negative 
result prevents us from concluding that Ypk1 directly phosphory-
lates Rps6. We did, however, observe synthetic lethality in ypk1 
and ypk3 double mutants (Supplemental Figure S3D). This obser-
vation provides genetic support to the idea that Ypk1 and Ypk3 
share common targets.
Glc7/Shp1 mediates TORC1/2-dependent phosphorylation 
of Rps6
Protein phosphatase 1 was recently proposed to mediate dephos-
phorylation of Ser-247 in Rps6 in mammalian cells (Hutchinson 
et al., 2011). Thus we investigated the role of PP1 in Rps6 dephos-
phorylation in yeast, using a loss-of-function mutant of Glc7, the 
catalytic subunit of yeast PP1 (Baker et al., 1997). Expression of the 
glc7-127 allele, which contains two point mutations, K110A and 
K112A, displays defects in glycogen accumulation and elevated 
levels of phosphorylation of histone H3 (Baker et al., 1997), blocked 
the dephosphorylation of Rps6 in response to rapamycin and BHS 
treatments, and led to higher basal phosphorylation levels under 
normal conditions (Figure 4A). In yeast, calyculin A is a known in-
hibitor of PP1 and to a lesser extent PP2A (Hoon et al., 2008). In-
triguingly, we found that strains expressing RPS6AA exhibited slight 
resistance to calyculin A treatment compared with the wild-type 
strains (Figure 4B). Calyculin A sensitivity of these cells could be 
partially rescued by the overexpression of GLC7, supporting the 
notion that Glc7 is the target of this drug (Supplemental Figure 
S4A). This observation linked Glc7 activity and Rps6 phosphoryla-
tion and suggested that constitutive hyperphosphorylation of Rps6 
is toxic, although other, indirect mechanisms could explain the ob-
served growth rescue.
Glc7 activity is regulated by numerous regulatory subunits. To 
identify the regulatory subunit involved in Rps6 dephosphorylation, 
we screened deletion mutants of genes encoding all known nones-
sential Glc7-interacting proteins for effects on Rps6 phosphoryla-
tion. This approach identified Shp1 as a protein required for the 
dephosphorylation of Rps6 upon rapamycin treatment (Supplemen-
tal Figure S4B). Deletion of SHP1 suppressed the effect of rapamy-
cin and BHS on Rps6 phosphorylation to an extent comparable to 
that of the glc7-127 allele (Figure 4C). These results functionally link 
Shp1 and Glc7 in the regulation of Rps6 dephosphorylation down-
stream of TORC1 and TORC2. The kinase and phosphatase path-
ways governing Rps6 phosphorylation described here are summa-
rized in Figure 4D.
Physiological characterization of Rps6 phosphomutants
To identify the physiological significance of Rps6 phosphorylation, 
we first compared the growth rates of cells expressing either wild-
type Rps6 protein or the nonphosphorylatable variant Rps6AA. In our 
FIGURE 4: Glc7/Shp1 mediates TORC1/2-dependent 
dephosphorylation of Rps6. (A) Exponentially growing cells of the 
indicated genotypes were treated with 200 nM rapamycin or 100 μM 
BHS for the indicated times before analysis of Rps6 phosphorylation. 
The glc7-127 allele suppressed both the rapamycin- and the BHS-
induced dephosphorylation of Rps6. (B) Strains of the indicated 
genotypes were diluted into medium containing drug vehicle (DMSO) 
or 5 μM calyculin A, and growth (optical density at 600 nM) was 
measured every 15 min for the following 16 h. (C) Like the glc7-127 
allele, deletion of SHP1 also suppressed both the rapamycin- and the 
BHS-induced dephosphorylation of Rps6. (D) Cartoon depicting the 
TORC1- and TORC2-regulated signaling pathways governing Rps6 
phosphorylation.
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and Supplemental Figure S5D). Further-
more, by Northern blot, we observed a 
delay in rRNA maturation in RPS6AA cells 
(Supplemental Figure 5E). In summary, RP-
S6AA cells display a 40S biogenesis defect 
but no obvious defect in global transla-
tion. These phenotypes are similar to what 
is observed in the absence of one of the 
two copies of the RPS6 genes (Pachler 
et al., 2004), and thus it is unclear whether 
the 40S biogenesis defect results from 
Rps6 hypophosphorylation or instead is 
due to reduced levels of Rps6AA protein 
(see Discussion).
To probe for a role of Ypk kinases in 
translation, we compared polysome profiles 
generated from wt cells to those generated 
from cells lacking Ypk1–3 activities. Because 
chronic inhibition of these kinases was not 
an option (the cells die), we chose to use an 
experimental setup in which we acutely acti-
vate translation in the presence or absence 
of Ypk1–3 activity. Specifically, ypk1as, 
ypk2Δ, ypk3 as cells were starved of glucose 
for 1 h and then refed with glucose with or 
without the analogue (1NM-PP1). Analysis 
of the abundance of the free subunits (40S 
and 60S), the monosomes (80S), and the 
polysomes collected after refeeding with or 
without 1NM-PP1 revealed that acute inhi-
bition of Ypks had no significant effect on 
the profiles under any of the conditions 
tested despite the expectant hypophos-
phorylation of Rps6 (Figure 5F and Supple-
mental Figure S5, F and G). These results 
are in accordance with a recently published 
study, which showed that the polysome pro-
files from wild-type and S6K1;S6K2−/− liver 
cells exhibited no significant differences un-
der starvation or refeeding conditions 
(Chauvin et al., 2014). Unlike RPS6AA cells, 
ypk3 cells displayed no defects in prolifera-
tion, protein accumulation, or 40S biogene-
sis (Supplemental Figure 5E; unpublished 
data).
Our polysome profiling results thus far demonstrate that Rps6 
phosphorylation plays no role in global translation but do not query 
for a potential role in the translation of individual messages. To 
probe for such a role, we performed ribosome profiling on ypk1as 
ypk2 ypk3as RPS6wt and ypk1as ypk2 ypk3as RPS6AA cells with or with-
out 1NM-PP1 (protocol in Supplemental Figure S6A). Specifically, 
we compared the profiles of these cells after 20 and 40 min of 
refeeding with glucose. Under these conditions, we observed ex-
pected patterns of Rps6, Ypk1, and Ypk3 phosphorylation (Supple-
mental Figure S6B). The majority of ribosome footprints were 28–32 
nucleotides (nt) long, and metagene analysis showed the expected 
triplet periodicity within coding regions (Supplemental Figure S6, C 
and D). For both RNA sequencing (RNA-seq) and ribo-seq reads, 
the ribosome profiling data exhibited good correlations for cover-
age between the replicas (Supplemental Figure S6E). We observed 
no strain-dependent differences in global mRNA levels (RNA-seq) 
or global translational efficiencies (TEs; Figure 6A), demonstrating 
wild-type and RPS6AA cells using sucrose gradient centrifugation. 
The ratios of polysomes to 80S monosomes were the same in these 
two strains (Figure 5C). However, the mutant cells exhibited an ele-
vated 60S peak, indicating an imbalance between the free subunits. 
Next we analyzed the polysome profiles of wild-type and RPS6AA 
cells upon glucose starvation and refeeding with glucose. Although 
the RPS6AA cells displayed an increase in the 60S peak in all of the 
conditions we tested, we did not detect other overt changes in the 
profiles compared with the wild-type cells under these conditions 
(Figure 5C and Supplemental Figure S5C).
To further investigate whether the elevated 60S peak is due to 
a defect in the production of the small subunit, we dissociated the 
monosomes and polysomes into free subunits in the presence of 
high salt. We observed that the level of 40S subunits was indeed 
lower in the mutant strain than in the wild type strain (Figure 5D). 
Quantitative Western blots confirmed that the ratio of Rps6 to a 
large-subunit protein, Rpl3, is reduced in RPS6AA cells (Figure 5E 
FIGURE 5: Physiological characterization of Rps6 phosphorylation. (A) Growth (OD600) of wt 
and RPS6AA cells in rich medium at 30°C was recorded every 15min for 16 h. (B) The protein 
content of exponentially growing wt and RPS6AA cells was measured by FITC staining and FACS 
analysis. (C) Polysome profiles of wt and RPS6AA cells. Cells were grown to exponential growth 
phase in SD medium containing 2% glucose. After filtering, cells were resuspended in SD 
medium lacking a carbon source and incubated at 30°C for 1 h. Subsequently, cells were refed 
with 2% glucose. Aliquots of cells were treated with cycloheximide before and after 60 min of 
starvation and after 20 min of refeeding. Polysome profiles from these three time points are 
shown. (D) Ribosomes extracted from wt and RPS6AA cells were incubated in the presence of 
800 mM KCl. Free 40S and 60S subunits were analyzed by sucrose gradient centrifugation. 
(E) The relative amount of Rps6 normalized to Rpl3 in protein extracts prepared from 
exponentially growing wt and RPS6AA cells was assessed by Western blot. (F) ypk1as ypk2 ypk3as 
cells starved of a carbon source for 60 min were subsequently refed with glucose in the 
presence of DMSO or 1NM-PP1. Twenty minutes later, cells were treated with cycloheximide, 
and polysome profiles were generated.
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2015). Only five (SED1, YCR007C, RPS21A, 
UIP5, Q0050) of 6692 transcripts displayed 
TE levels with absolute Z-scores ≥3 relative 
to the wild type in both Rps6AA and Ypk-in-
hibited cells (Figure 6B and Supplemental 
Figure S7). We note that five is close to the 
expected number of transcripts to be se-
lected by chance with this Z-score cutoff. 
Indeed, the profiles of SED1 and UIP5 when 
assessed manually did not display obvious 
differences between conditions (Figure 7A). 
We also assessed in detail the transcript 
profiles of a number of known housekeep-
ing genes (e.g., ACT1), as well as ribosomal 
protein genes (e.g., RPS6B) and Ribi genes 
(e.g., TEF4) whose expressions are known 
to be strongly dependent on TORC1 activ-
ity (Lippman and Broach, 2009; Huber et al., 
2011). None of the selected transcripts ex-
hibited a striking change in profile across 
the different conditions (Figure 7A). Neither 
Rps6AA mutation nor Ypk activity affected 
translational efficiency of transcripts pos-
sessing introns (e.g., ACT1, RPS6B, TEF4; 
Figure 7A) and/or transcripts whose transla-
tion is regulated by upstream open reading 
frames (ORFs; e.g., GCN4). These observa-
tions do not support a role of Rps6 phos-
phorylation in the pioneer round of transla-
tion and/or in reinitiation.
Next we compared ribosome occupancy 
of 5′ leaders and 3′ untranslated regions 
(UTRs) across the different conditions. The 
number of footprints mapping to 3′ UTRs 
remained constantly low regardless of the 
phosphorylation status of Rps6 (Figure 7B). 
At 20 min, the number of footprints map-
ping to 5′ leaders was lower in RPS6AA cells 
in both replicas; however, the difference was 
not higher than replicate variation. We hy-
pothesized that the changes in 5′ leader 
densities may occur in specific mRNAs and 
analyzed the changes in the relative density 
between 5′ leaders and coding regions. The 
observed changes between different condi-
tions did not exceed those observed for the 
replicas obtained for the same conditions 
(Supplemental Figure S7B). A similar, less 
robust trend was observed in Ypk-inhibited 
cells.
Finally, we explored a possible role for 
Rps6 phosphorylation in frameshifting. Dur-
ing ribosomal frameshifting, a proportion of 
ribosomes shift their reading frame to pro-
duce a protein product that is encoded by 
two ORFs. The ribosome density profiles for 
such mRNAs are normally characterized by 
a drop of density downstream of ORF1 and 
a change in the phase of the triplet periodicity between nonover-
lapping regions of ORF1 and ORF2, which is consistent with the 
direction of frameshifting (Michel et al., 2012). The drop of density 
should correlate with frameshifting efficiency and thus could be 
that, under these conditions, Rps6 phosphorylation does not 
strongly affect gene regulation at the level of either transcription or 
translation. To identify potential differential gene expression, we 
used Z-score transformation as described earlier (Andreev et al., 
FIGURE 6: Differential gene expression analysis. (A) Scatter plots showing Z-scores (y-axis) of 
fold changes relative to wild-type control of ribosome occupancy (Riboseq), transcript levels 
(RNAseq), and translation efficiency (TE). Transcripts are ordered based on their log2 minimal 
expression signal (x-axis). Transcripts with |Z| ≥ 3 are shown in red. (B) Venn diagrams showing 
the number of transcripts whose changes in ribosome occupancy, transcript levels, or TE levels 
exceed a |Z| ≥ 3 threshold vs. wild-type controls in the indicated conditions.
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FIGURE 7: Alternative translational processes occur independently of Rps6 phosphorylation status. (A) Ribo-seq and 
RNA-seq densities obtained from the six different conditions/time points mapped to genomic loci of individual genes. 
Ribo-seq densities are indicated with different colors, depending on the condition (indicated at the bottom). Combined 
RNA-seq densities of all six conditions are shown in gray. Locations of coding regions are indicated with black bars 
under each profile, introns with black lines, and upstream open reading frames with red bars. Genomic coordinates are 
given for the sense strand relative to the start codons, with the first nucleotide of the start codons as the zero 
coordinate. (B) The number of footprints mapped to 5′ leaders and 3′ UTRs normalized to the number of footprints 
mapped to coding sequences (CDS) are shown for each Ribo-seq replicate. (C) Analysis of ribosome footprint densities 
on mRNAs for the genes that require ribosomal frameshifting for their expression. Footprint densities are shown 
separately for all conditions and two replicas. The ORF plot for each gene is shown below the density plots, ORF1 is 
highlighted in blue, and a nonoverlapping part of ORF2 is highlighted in yellow. The total number of reads aligning to 
each of the two areas is indicated on the right side of each plot, along with footprint density within ORF2 relative to 
ORF1. Histograms above represent periodicity within both ORFs. It can be seen that the phase of periodicity shifts 
according to the expected +1 directionality of ribosomal frameshifting.
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This conservation across the distantly related yeasts S. cerevisiae and 
S. pombe predicts that TORC2 will similarly be important for S6 
phosphorylation in higher eukaryotes. Curiously, although we ob-
served direct phosphorylation of Rps6 by Ypk3 in vitro, we failed to 
observe Rps6 phosphorylation by Ypk1 in the same assay. This was 
surprising, given the dependence of Rps6 phosphorylation on the 
activity of these kinases in vivo and the strong homology among all 
three Ypks and mammalian S6K1/2. Perhaps phosphorylation of 
Rps6 by Ypk1/2 occurs in a cellular context that is not recapitulated 
in the in vitro assay.
Although Ypk1 and 2 are well-established effectors of TORC2, 
direct phosphorylation of Ypk3 by TORC1 is novel and extends pre-
vious work (Gonzalez et al., 2015). Specifically, we found that Ypk3 
physically interacts with TORC1 in vivo in a rapamycin-sensitive 
manner. We mapped four rapamycin-sensitive phosphorylation sites 
on the C-terminal end of Ypk3 and demonstrated that they are indis-
pensable for its activity as an S6 kinase. However, expression of the 
phosphomimetic mutant of Ypk3 failed to suppress rapamycin-in-
duced Rps6 dephosphorylation, leading us to hypothesize that 
TORC1 might regulate not only Rps6 phosphorylation, but also its 
dephosphorylation.
In this vein, we found that Glc7/PP1 is the phosphatase respon-
sible for dephosphorylation of both Ser-232 and Ser-233. We further 
demonstrated that the Glc7 regulator Shp1 is also necessary for 
Rps6 dephosphorylation. Shp1, in complex with the AAA-ATPase 
Cdc48, promotes the assembly of Glc7–Sds22–Ypi1 complexes 
(Cheng and Chen, 2015). However, the mechanism by which TOR 
complexes interfere with Glc7 and/or Shp1 activities remains to be 
elucidated. Intriguingly, preliminary data show that Shp1 is phos-
phorylated in a rapamycin-sensitive manner (unpublished data).
Previously we proposed that Sch9, another AGC kinase and 
TORC1 effector, could serve as the yeast S6K (Urban et al., 2007). 
Consistently, we found that expression of a rapamycin-insensitive 
variant of Sch9 delays rapamycin-induced Rps6 dephosphorylation 
(unpublished data). However, unlike YPK3 deletion, SCH9 deletion 
did not compromise Rps6 phosphorylation (unpublished data). 
Thus we no longer believe that Sch9 is truly an S6 kinase. At present, 
we favor the idea that Sch9 signals block Rps6 dephosphorylation. 
This could be direct, via Shp1 phosphorylation, or, indirect, via its 
influence on translation initiation (Urban et al., 2007).
What function does Rps6 phosphorylation serve?
Previous attempts to identify the physiological importance of Rps6 
phosphorylation in yeast led to the observation that Rps6 phos-
phorylation had no obvious effect on growth under a variety of 
stress conditions or during sporulation (Kruse et al., 1985; Johnson 
and Warner, 1987). Unexpectedly, in our yeast background (TB50a), 
we found that the RPS6AA mutations result in a lower proliferation 
rate and protein content than with the wild-type cells, which is likely 
due to reduced levels of Rps6AA protein. Furthermore these cells 
present a 40S ribosome biogenesis defect evident at both the pro-
tein level and rRNA processing level. These phenotypes are not 
apparent under conditions in which wild-type Rps6 protein is hypo-
phosphorylated. From these results, we conclude that one must be 
extremely cautious when assigning phenotypes obtained from cells 
expressing nonphosphorylatable variants of Rps6 to lack of Rps6 
phosphorylation.
To complement our biochemical efforts, we also used synthetic 
genetic array (SGA) technology (Tong et al., 2001) to probe for syn-
thetic interactions in triple mutants containing RPS6AAA, RPS6BAA, 
and each nonessential gene deletion. The two validated hits that 
we obtained from this assay were dom34 and hbs1, each of which 
used to assess differences in frameshifting efficiencies between 
samples.
To obtain information on S. cerevisiae genes that require pro-
grammed ribosomal frameshifting for their expression (ABP140, 
EST3, OAZ1, and TY1 transposable element), we used the Recode-2 
database (Bekaert et al., 2010). The EST3 mRNA had insufficient 
coverage for the analysis. Profiles of ribosome density for ABP140, 
OAZ1, and two arbitrary chosen copies of TY1 element are shown in 
Figure 7C. Because the ambiguous alignments were used for frame-
shifting analysis (see Materials and Methods), profiles for TY1 ele-
ments represent mRNA translation of several TY1 copies that share 
strong sequence similarity.
We observed a change of triplet periodicity consistent with the 
known directionality of frameshifting in all cases; however, the ob-
served variation in the drop of ribosome density was insignificant 
among various samples in comparison to the variation observed be-
tween replicas (Figure 7C).
In summary, consistent with previous work (Chauvin et al., 2014), 
we found that Rps6 phosphorylation plays no role in global protein 
synthesis upon refeeding as assessed by polysome profiling. To 
probe for potential affects on the translation of individual transcripts, 
we exploited a recent technological advance in the translation 
field—ribosome profiling. Specifically, using ribosome profiling, we 
assessed changes in RNA levels and translation efficiencies of indi-
vidual mRNAs at the scale of the whole transcriptome (Supplemen-
tal Figure S7) under conditions in which Rps6 was or was not phos-
phorylated. We used a relaxed threshold of statistical significance to 
call for differential expression (|Z|-score ≥ 3), for which 0.25% of ana-
lyzed genes are expected to be classified as differentially expressed 
by chance under the assumption that changes in coverage due to 
technical factors follow a normal distribution. Even under these re-
laxed thresholds, we failed to identify differentially expressed genes 
that would be shared between Rps6 mutants and Ypk-inhibited cells 
at all time points (Figure 6B).
DISCUSSION
The pathways regulating Rps6 phosphorylation in budding yeast 
have remained ambiguous and, in higher eukaryotes, surprisingly 
complex. Furthermore, the physiological role of Rps6 phosphoryla-
tion has remained mysterious for the past four decades. Rps6 is a 
constitutive component of the 40S small subunit of the ribosome, 
and, since its phosphorylation is promoted downstream of anabolic 
stimuli, this modification has long been assumed to promote protein 
synthesis. However, experimental evidence supporting such a role 
has not been forthcoming. In this study, we defined the signaling 
cascades that regulate Rps6 phosphorylation in budding yeast. We 
demonstrated that nonphosphorylatable Rps6 knock-ins do not ac-
curately mimic the function of hypophosphorylated protein. Finally, 
using ribosome profiling, we found little evidence to support a role 
for Rps6 phosphorylation in the regulation of translation per se. We 
are thus compelled to conclude that whatever role Rps6 phosphory-
lation plays, this role is not directly related to mRNA translation.
Both TORC1 and TORC2 influence Rps6 phosphorylation
In the present work, we demonstrate for the first time that the two 
phosphorylation sites on the C-terminus of Rps6 are differentially 
regulated in yeast and that this regulation is dependent on both 
TORC1 and TORC2. Specifically, we show that TORC1, via Ypk3, 
regulates Ser-232 and Ser-233 phosphorylation, whereas TORC2, via 
Ypk1 and, to a lesser extent, Ypk2, regulates Ser-232 phosphoryla-
tion. Rps6 phosphorylation thus appears to be similarly regulated in 
budding and fission yeast (Du et al., 2012; Nakashima et al., 2012). 
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RPS6AA cells and, to a lesser extent, in cells lacking Ypk1–3 activities. 
Ribosomes accumulate on 5’ leaders in starved cells (Ingolia et al., 
2009), but the physiological role underlying this phenomenon is un-
known. The observed reduction requires further study to assess its 
statistical significance under the tested conditions.
Recent work implicated S6 kinases and Rps6 phosphorylation in 
the ribosome biogenesis transcriptional program in mouse liver 
(Chauvin et al., 2014). Although such a function could potentially be 
conserved in yeast, after analysis of our mRNA-seq data used for the 
ribosome profiling, we failed to detect Rps6 phosphorylation–de-
pendent transcriptional regulation of any mRNA subgroups. Thus, 
like translation elongation, the influence of Rps6 phosphorylation 
on transcription appears to be restricted to higher eukaryotes.
MATERIALS AND METHODS
Yeast cultures and inhibitor concentrations
S. cerevisiae strains and plasmids used in the study are listed in Sup-
plemental Tables S1 and S2. Standard protocols were followed to 
obtain the strains. Cells were grown in YPD (1% yeast extract, 2% 
peptone, 2% glucose) at 30°C if not indicated otherwise.
Rapamycin was used at 200 ng/ml, wortmannin at 10 μg/ml, and 
cycloheximide at 25 μg/ml.
Cells for carbon starvation experiments were grown in complete 
synthetic medium with glutamine (Gln) as the nitrogen source at 
30°C, filtered, and resuspended in the same medium lacking a car-
bon source or with galactose instead of glucose (Glc). At the indi-
cated times after the medium change, either 2% Glc or an equal 
amount of water was added into the cultures. After further incuba-
tion for the indicated times, aliquots of cells were collected for pro-
tein extraction.
Cells for nitrogen starvation experiments were grown in yeast 
nitrogen base (YNB) (-N) + 2% Glc, 0.2% Gln, filtered, and resus-
pended in YNB (-N) + 2% Glc. At 20 min later, either 0.2% Gln or an 
equal amount of water was added to the cell cultures.
For spot assays, cells grown overnight were diluted to OD600 nM 
= 0.1 and grown to exponential phase. Serial dilutions at 1:10 were 
spotted after normalization of cell numbers. The plates were incu-
bated for 2–3 d at 30°C.
For growth assays, exponentially growing cells were diluted to 
OD600 nM = 0.005 in the indicated media. A 200-μl amount of cells 
along with 2 μl of drug solution or drug vehicle alone per well was 
dispensed in 96-well plates, and the OD600 nM of the wells was re-
corded every 15 min for 16–24 h at 30°C. The average and SD val-
ues were obtained from at least three independent experiments.
Antibodies
For total Rps6 antibody, guinea pig polyclonal antiserum was raised 
against the peptides RVFFDKRIGQEVDGE and QRALKVRNAQA-
QREA, and affinity purified (Eurogentec, Seraing, Belgium). Supple-
mental Figure S1b shows the specificity of the antibodies. Other 
antibodies used in this study were rabbit anti–phospho-S6 ribo-
somal protein (S235/S236) at 1:2000 (Rps6-PP; 4858S; Cell Signal-
ing Technology, Danvers, MA), rabbit anti–phospho-Akt substrate 
(RXXS*/T*) at 1:5000 (9614S; Cell Signaling), rabbit anti-Hog1 at 
1:1000 (y-215; Santa Cruz Biotechnology, Dallas, TX), mouse anti-
Rpl3 at 1:5000 (Developmental Studies Hybridoma Bank, Iowa City, 
IA), mouse anti-Flag at 1:1000 (F1804; Sigma-Aldrich, St. Louis, 
MO), rabbit anti–Ypk1 pT662 at 1:500, rabbit anti–Sch9 pT737 at 
1:500, goat anti-Ypk1 at 1:1000 (yl-15; Santa Cruz Biotechnology), 
and the corresponding IRDye infrared dye–labeled secondary anti-
bodies at 1:10,000 (Li-Cor Biosciences, Lincoln, NE). The signals 
were detected by Odyssey Imaging Systems.
displayed a synthetic sick phenotype in combination with RPS6AAA, 
RPS6BAA (unpublished data). Dom34 and Hbs1 function together in 
no-go mRNA decay (Doma and Parker, 2006; Harigaya and Parker, 
2010), but dom34 and hbs1 display synthetic sick interactions with 
most deletion mutants of 40S ribosomal protein paralogues 
(Costanzo et al., 2010). This observation again suggests that it is the 
reduced levels of Rps6AA protein and not the lack of Rps6 phos-
phorylation that underlies this synthetic interaction. There are now 
ample data to suggest that many ribosomal proteins perform non–
ribosome-related tasks (Warner and McIntosh, 2009). If Rps6 phos-
phorylation were involved in such a function, one might hope that 
this could have been discovered through this SGA approach.
We also made the interesting observation that RPS6AA mutation 
increases resistance to the PP1 inhibitor calyculin A. The simplest 
interpretation of this result is that hyperphosphorylation of Rps6 is 
toxic. Consistently, RPS6DD cells were found to be inviable, which, 
unfortunately, makes their further characterization an intriguing but 
challenging prospect.
Recent structural studies showed that Rps6 is located far from 
the decoding center, accessible from the solvent side of the 40S 
subunit (Ben-Shem et al., 2011; Khatter et al., 2015). According to 
these structures, the C-terminal end of Rpl24 relocates and interacts 
with Rps6 during translocation. The functional significance of this 
interaction remains to be elucidated. Unfortunately, the C-terminus 
of Rps6 is missing from these structures, making it challenging to 
define a function for the phosphorylation of this domain from these 
structural studies.
Previous studies addressing the physiological function of Rps6 
phosphorylation in higher eukaryotes suggested that Rps6 phos-
phorylation slows translation elongation (Ruvinsky et al., 2005; 
Chauvin et al., 2014). These are elegant studies, but because they 
use deletion of the S6 kinases and knock-in alleles of Rps6, they can-
not account for the likely cellular adaptation that occurs in response 
to these chronic deficiencies, as the authors acknowledge. Here we 
also queried whether Rps6 phosphorylation plays a role in translation 
in yeast. To this end, we generated both polysome profiles and ribo-
some profiles from wt, RPS6AA, and Ypk-inhibited cells after refeed-
ing with glucose to stimulate translation. Of importance, our ability 
to acutely inactivate the kinases responsible for Rps6 phosphoryla-
tion avoids potential confounding effects arising from cellular adap-
tation. After extensive analyses, an overt role for Rps6 phosphoryla-
tion could be ascribed to neither global translation nor translational 
regulation of specific subsets of mRNAs. Specifically, we sought 
changes in global transcription that would have been apparent in the 
polysome profiling, whereas transcript-specific effects would have 
been observable in the ribosome profiling. We found no changes in 
the density of ribosome-protected fragments across conditions, im-
plying that Rps6 phosphorylation does not affect the rate of protein 
synthesis of individual transcripts. In addition, alternative transla-
tional processes, including pausing, frameshifting of specific mes-
sages, reinitiation on GCN4 transcripts, and global stop-codon 
readthrough, appeared to occur independently of the phosphoryla-
tion status of Rps6. Finally, and in contrast to previous studies, our 
experimental setup was chosen to potentially expose a role of Rps6 
phosphorylation in the pioneering round of translation of individual 
transcripts. Specifically, we assumed that refeeding of cells after 1 h 
of glucose starvation would trigger inaugural translation of newly 
transcribed messages, which would be visualized at one of the two 
ribosome profiling time points. Thus, under the experimental condi-
tions used, we find no evidence to support a role for Rps6 phos-
phorylation in any aspect of translation. One exception to this 
general conclusion is the reduction of ribosomes on 5’ leaders in 
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pH 7.0, 50 mM NH4Cl, 12 mM MgCl2, 1 mM DTT). Gradients were 
ultracentrifuged for 3.5 h at 35,000 rpm, and the ultraviolet profile 
was recorded using an IG gradient fractionator.
Ribosome profiling
The ypk1as ypk2 ypk3as RPS6wt and ypk1as ypk2 ypk3as RPS6AA cells 
were grown in minimal synthetic medium with 2% Glc and 0.2% Gln 
at 30°C. Once they reached exponential growth, the cells were fil-
tered and resuspended in minimal synthetic medium with 0.2% Gln 
without any carbon source. After a 1-h incubation at 30°C, cells 
were treated with 500 nM 1N-PP1 or dimethyl sulfoxide (DMSO). 
After a 5-min incubation with the drug/vehicle, the cells were refed 
with 2% glucose. After 20 or 40 min, cells were collected by filtra-
tion, resuspended in polysome buffer, and frozen rapidly in liquid 
nitrogen.
Ribosome footprint and total RNA libraries were prepared using 
the ARTseq Ribosome Profiling Kit (Yeast, RPYSC12116; Epicentre, 
Madison, WI) according to the manufacturer’s protocol with slight 
changes. For the preparation of ribosome-protected RNA frag-
ments, 20 μg of nuclease-digested RNA samples were run on a 
12% urea-polyacrylamide gel before rRNA depletion. The gel slices 
corresponding to fragment sizes of 28–30 nt were excised, and 
samples purified from these slices were further used for rRNA de-
pletion and library preparation. The libraries were sequenced on an 
Illumina HiSeq2500 machine on the Genomics Platform (Geneva, 
Switzerland).
Initial processing and alignment of sequence reads
Adapter sequence (5′-AGATCGGAAGAGCACACGTCT-3′) was 
trimmed from raw reads using Cutadapt (Martin, 2011). To reduce 
contamination from noncoding RNAs (such as rRNAs, tRNAs, 
small nuclear RNAs, and small nucleolar RNAs), trimmed reads 
were aligned to relevant sequences downloaded from the Sac-
charomyces Genome Database (Cherry et al., 2012; (downloads 
.yeastgenome.org/sequence/S288C_reference/rna/rna_coding 
.fasta.gz), using the Bowtie short read alignment program 
(Langmead et al., 2009), and no more than three mismatches were 
allowed for these alignments (-v 3). Reads aligning to these se-
quences were removed from the data set for further analysis. 
Read-length distributions were analyzed to determine the most 
prevalent read lengths among the samples. Reads of <20 or 
>80 nt were discarded from further analyses.
The S. cerevisiae genome was obtained from the National 
Center for Biotechnology Information (GCA_000146055.2, dated 
December 2013; Engel et al., 2014), to which reads were aligned 
using Bowtie (Langmead et al., 2009). Parameters used for Bowtie 
alignments were -m 1 -v 3, that is, no more than three mismatches 
were allowed, and nonunique mappings were discarded. To evalu-
ate the number of reads mapped on each gene, gene annotations 
were procured from the Saccharomyces Genome Database (Cherry 
et al., 2012). Reproducibility of the data from all the replicates was 
evaluated by calculating Pearson’s r. Specifically, the number of raw 
reads mapped on each gene for ribosomal profiling (two replicates) 
and total RNA-seq (three replicates) were used for calculating a 
Pearson’s r.
Metagene analysis
Genes with at least 100 mapped alignments were used for the pro-
duction of metagene profiles at the location of translation initiation 
and termination. To analyze the read density around the initiation 
and termination sites, 30 nt upstream and downstream of the start 
and stop codons were used, respectively.
Denaturing protein extraction
Protein extraction was performed based on the trichloroacetic acid–
urea extraction method as previously described (Urban et al., 2007). 
PPi: 10 mM NaF, 10 mM p-nitrophenylphosphate, 10 mM Na2P2O4, 
and 10 mM β-glycerophosphate. PI: 1× Roche protease inhibitor 
cocktail and 1 mM phenylmethylsulfonyl fluoride.
Extraction of ribosomes
Exponentially growing cells were treated with 0.1 mg/ml cyclohexi-
mide (CHX). After 10 min of incubation, cells were harvested, 
washed, and lysed with ribosome lysis buffer (10 mM Tris-HCl, 
pH 7.4, 100 mM NaCl, 30 mM MgCl2, 100 μg/ml CHX, 200 μg/ml 
heparin). The extract was centrifuged for 10 min at 13,000 rpm at 
4°C. The OD260 of 1:100 dilutions of the supernatant was measured. 
After the addition of glycerol with the final concentration of 10%, 
the samples were stored at −70°C.
Preparation of recombinant proteins and kinase assays
Purification of TORC1 from RL170-2c cells was performed as de-
scribed previously for TORC2 (Gaubitz et al., 2015). Glutathione S-
transferase (GST)–Ypk3 was expressed under a galactose-inducible 
promoter in yeast from a 2-μ plasmid. After a 4-h galactose induc-
tion, yeast extract was prepared, and the fusion protein was purified 
using Glutathione Sepharose 4B from GE Healthcare Life Sciences 
(Little Chalfont, United Kingdom) according to the manufacturer’s 
instructions. The eluted protein was dialyzed, aliquotted, and frozen 
at −70°C. TORC1 kinase reactions were performed in kinase buffer 
(2.5 mM 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfo-
nate [CHAPS], 25 mM 4-(2-hydroxyethyl)-1-piperazineethanesul-
fonic acid [HEPES], 150 mM KCl, 5 mM MgCl2, and 1 mM dithioth-
reitol [DTT]) in a final volume of 30 μl. Reactions were started with 
the addition of 300 μM ATP, 125 mM MgCl2, and 10 μCi of [γ-32P]
ATP and then shaken for 20 min at 30°C. After the addition of 6 μl of 
6× SDS–PAGE sample buffer, samples were heated to 65°C for 
10 min. Samples run in SDS–PAGE gels were stained with SYPRO 
Ruby Protein Gel Stain (Thermo Fisher Scientific, Waltham, MA) and 
analyzed using a Bio-Rad Molecular Imager.
For Ypk3 and Ypk1 kinase assays, ribosomes were used as sub-
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Differential gene expression analysis
Normalization of mapped reads was performed by dividing the total 
number of reads mapped in a sample by the total number of the 
reads mapped for the sample containing the lowest number of 
mapped reads. This was performed separately for ribo-seq and 
RNA-seq samples. Ribosomal profiling reads were assigned to gene 
coordinates based on the inferred location of the A-site. The A-site 
codon of the elongating ribosome was assigned at 15 nt down-
stream of the 5′ end of reads of length 28–32.
Average read counts for each gene for ribosomal profiling data 
(two replicates) and RNA-seq data (three replicates) were used for 
differential gene expression calculation. The read counts were com-
pared in a pairwise manner between mutants and wild type and 
between different time points for the same treatments. The Z-score 
transformation of change fold log ratios was carried out as described 
previously (Andreev et al., 2015). In brief, genes were grouped into 
bins of 300 based on the lowest expression signal (ribo-seq or RNA-
seq or both across compared conditions). Variation in the distribu-
tion of change fold ratios was used to calculate the Z-score. Profiles 
for differentially regulated genes were constructed by calculating 
the average of normalized reads mapped on each position of the 
gene based on the inferred location of the A-site.
Assigning mapped reads to 5′ leaders, 3′ UTRs, and coding 
sequence regions
Genomic alignments were used to assign reads to 5′ leaders, 3′ 
UTRs, and coding sequence (CDS) regions. The 5′ leaders and 3′ 
UTR annotations were obtained from Nagalakshmi et al. (2008). 
Reads were assigned to 2755 genes that have both 5′ leaders and 
3′ UTRs annotated, and genes with overlapping features were dis-
carded for this analysis. End positions of 5′ leaders were modified to 
17 nt upstream of the first base of the CDS, and start positions of 3′ 
UTRs were modified to 13 nt upstream of the last base of the CDS. 
Upstream ORFs were analyzed for differential expression using the 
same procedure as for CDS regions.
Frameshift analysis
Ribo-seq reads aligning to no more than 100 locations were used for 
generating ribosome density profiles for S. cerevisiae genes 
(ABP140, EST3, OAZ1) and the TY1 transposable element, which 
are known to use +1 frameshifting in their expression (Bekaert et al., 
2010). For analysis of triplet periodicity, only 29-nt-long reads were 
used. The fraction of reads aligning to each subcodon position of 
the A-site (using 15-nt offset from its 5′ end) from all conditions was 
calculated to assess triplet periodicity.
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